Teva Pharmaceuticals Recalls Two Medicines for the Treatment of High Blood Pressure Due to Potential Cancer Risk.
The recall includes two combination preparations: amlodipine / valsartan combination tablets and amlodipine / valsartan / hydrochlorothiazide combination tables.
An impurity called N-nitroso-diethylamine (NDEA) might be in the drugs. NDEA is a human carcinogen. This chemical is typically found in very small quantities in certain foods, drinking water, air pollution, and certain industrial processes.
If you have any concerns, please call Teva at 1-888-838-2872.